Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Idun discloses new inhibitors of ICE and related proteases

June 24, 1998

Collgard Biopharmaceuticals establishes U.S. subsidiary

June 22, 1998

New agent for rheumatoid arthritis in development by Toray and Kaken

June 19, 1998

MMP-2 and MMP-3 inhibitors identified at Warner-Lambert

June 19, 1998

Angiotech's micellar paclitaxel enters clinic for arthritis

June 18, 1998

Topical antiinflammatory corticosteroid approved for marketing in Japan

June 17, 1998

Santen presents new LTA4 hydrolase inhibitors

June 15, 1998

Preparation and use of new MMP inhibitors from Warner-Lambert

June 12, 1998

Procter & Gamble reveals new series of metalloprotease inhibitors

June 12, 1998

Warner-Lambert team describes preferential inhibitors of MMP-2 and MMP-3

June 11, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...